Pfizer on Wednesday named a longtime Novartis executive the leader of an oncology division it is leaning on to win back the support of investors in the years ahead.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,